Elsevier

Journal of Hepatology

Volume 34, Issue 4, April 2001, Pages 555-561
Journal of Hepatology

Differential expression of CD44 isoforms during liver regeneration in rats

https://doi.org/10.1016/S0168-8278(00)00065-9Get rights and content

Abstract

Background: CD44 is a transmembrane glycoprotein known to bind hyaluronic acid (HA). This molecule is a multifunctional cell surface glycoprotein involved in lymphocyte homing and activation, tumor growth and metastasis. We have investigated the qualitative modification of CD44 in the regenerating liver as a model for studying cellular proliferation in vivo. Molecules involved in cell adhesion and the extracellular matrix (ECM), which influence differentiation, growth, cell–cell interactions and cellular polarity, play an important role in the liver regeneration. We studied the modulation of CD44 gene expression and its post-transcriptional modifications, analyzing the expression of different isoforms containing exon v6 in the regenerating liver, in sham operated liver and in the hepatoma cells H-35.

Methods: The expression of CD44 and CD44v6 were analyzed in RNA extracted from regenerating liver at different times after partial hepatectomy (PH), and H-35 hepatoma cells by Northern blot, RT-PCR and Southern blot, and in protein extracts from regenerating liver by Western blot. H-35 hepatoma cells were assayed with the antibody cross-linked technique with CD44 antibodies.

Results: The standard CD44 form is expressed in regenerating liver and its levels were not modified following PH. However, our analysis revealed CD44 isoforms containing v6 in the first hours after PH as well as in the H-35 hepatoma cell line. H-35 cells treated with cross-linked anti-CD44 antibodies or HA show an increased rate of incorporation of [3H]thymidine (30 and 25%, respectively) with respect to the control.

Conclusion: These findings suggest that CD44 may play a role in the proliferation of residual hepatocytes following PH.

Introduction

CD44 is a multifunctional cell surface glycoprotein [1] involved in lymphocyte homing and activation, inflammation, tumor growth and metastasis [2]. CD44 standard form (CD44s) is expressed in lymphocytes, most mesenchymal and epithelial cells, and it is detected at high levels in some tumor cells [3]. CD44 acts as a receptor for hyaluronic acid (HA) and other extracellular matrix (ECM) components. An important feature of CD44 is the intracellular domain where the phosphorylation of two serine residues seems to be crucial for the activation of different signal transduction pathways [4], [5]. The transmembrane interaction between CD44 and the cytoskeleton is essential in the onset of oncogenesis and tumor progression [6]. Its heterogeneity is due to alternative splicing and post-translational modifications that affect the extracellular domain [7], [8], [9]. The analysis of the CD44 genomic structure in the rat, mouse and human has revealed that the alternative splicing involves the differential use of at least ten exons [9], [10]. The differential incorporation of these exons that gives rise to CD44 variants plays an important role in the process of tumor metastasis. It has been demonstrated that the stable transfection of a specific spliced form of CD44, containing the isoform pMeta, into a non-metastatic cell line confers metastatic properties [11]. This isoform differs from the standard form in that it includes an extra domain of 162 amino acids (224–385). Functional experiments conducted by repeated injection in vivo of a monoclonal antibody directed against this specific epitope of the CD44 isoform or by a soluble human CD44-immunoblogulin fusion protein prevent metastasis in target organs by blocking lymphogenic invasion [12], [13]. The presence of exon v6 in different isoforms of CD44 has been found not only in activated T-cells [14], but also in different tumors, which seems to confer metastatic characteristics [15], [16], [17]. The presence of isoforms containing v6 has been associated in humans with tumor development and the metastatic potential of colorectal cancer, squamocellular carcinoma and breast cancer [18], [19], [20]. In a similar analysis of hepatocellular carcinoma, the presence of variant proteins containing v3 and v6 has been demonstrated [21].

One of the most useful experimental tools to study the proliferation in vivo is represented by liver regeneration. In the rat, following 70% hepatectomy, the remaining hepatocytes begin to proliferate rapidly, entering the S-phase after 12–18 h [22]. DNA synthesis in non-parenchymal cells (NPC) begins 24 h later. The cells continue to proliferate until the original cellular mass is reconstituted. In rats, the hepatic mass is restored in about 10–15 days [23], [24]. Many factors and signal transduction pathways have been shown to play a role in regulating the hepatocyte proliferation that follows partial hepatectomy (PH) [25], [26], [27], [28]. Growth factors, hormones, transcription factors and biochemical changes in parenchymal cells have all been implicated as regulators of regeneration, but until now, the mechanisms controlling this proliferative process have been poorly understood [23], [29], [30], [31]. Molecules involved in cell adhesion and the ECM, which influence differentiation, growth, cell–cell interactions and cellular polarity, play an important role in the regenerating liver [32], [33]. Studies on the expression of fibronectin and α5-β1-integrin have demonstrated a 6–8-fold increase at 12–24 h after PH, suggesting that fibronectin mediates adhesion between hepatocytes and the ECM during the regenerating process [34], [35]. Other authors have studied components of the ECM, e.g. laminin, the expression of which is modulated during hepatic regeneration; however, their precise function is poorly understood [33], [34], [35], [36].

In this study, we investigated the qualitative modifications of CD44 in regenerating liver, which represents a powerful model system for studying cellular proliferation in vivo. We analyzed the modulation of CD44 gene expression and post-transcriptional modifications of CD44 in a proliferating system. We examined the expression of different isoforms containing exon v6 in the regenerating liver. Furthermore, we studied CD44 expression in the hepatoma H-35 cell line, the properties of which closely resemble those of proliferating hepatocytes during liver regeneration [37].

Section snippets

Animals

The experiments were performed on 3-month-old male Sprague–Dawley rats. The animals received humane care according to National Institute of Health (NIH) guidelines. The surgical procedures were performed between 08:00 and 24:00 h under ether anesthesia. The animals were partially hepatectomized, according to Higgins and Anderson's procedure, removing approximately 70% of the liver mass [38]. As a control, sham operations (SO) were performed (transverse abdominal incision followed by digital

CD44 expression during liver regeneration

To study the role of CD44 in liver regeneration, we first analyzed its expression in rat liver at different times following PH. For this purpose, Poly(A)+ mRNA was analyzed by Northern blotting and hybridized with a cDNA probe specific for CD44. Our results revealed the presence of two transcripts, the levels of which were not modified during the first 72 h following PH (Fig. 1A). The expression of CD44 protein in normal and regenerating liver was also analyzed by Western blotting using a mouse

Discussion

The rat regenerating liver provides an excellent model to study a proliferative process in vivo. In the present study, we described a possible role played by CD44 and its isoform, CD44v6, in liver regeneration and in the regulation of proliferation. Many authors have shown that CD44v6 is expressed in a variety of tumors [46]. The ability to metastasize in some tumors is linked to the expression of v6 in different CD44 isoforms [46]. Recently, the presence of a spliced form of CD44 containing v6

Acknowledgements

The authors would like to thank the other members of their laboratory, D. Bartoli, D. Piobbico, M. Castelli, S. Brancorsini and A. Giacomucci for fruitful discussions and the preparation of this paper. The authors are grateful to P. Sassone-Corsi, N.S. Foulkes, E. Lalli, G.M. Fimia and A. Columbano for critical reading and suggestion on the manuscript. Thanks are extended to S. Pagnotta and M. Coli for the excellent technical assistance and to Dr J.W. Koontz for the gift of the H-35 hepatoma

References (57)

  • E. Ayroldi et al.

    CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis

    Blood

    (1995)
  • M. Haramaki et al.

    Expression of CD44 in human hepatocellular carcinoma cell lines

    Hepatology

    (1995)
  • L.Y. Bourguignon et al.

    Interaction between the adhesion receptor CD44 and the oncogene product, p185HER2, promotes human ovarian tumor cell activation

    J Biol Chem

    (1997)
  • R. van der Voort et al.

    Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met

    J Biol Chem

    (1999)
  • M.S. Sy et al.

    CD44 as a marker in human cancer

    Curr Opin Oncol

    (1997)
  • S.J. Neame et al.

    Phosphorylation of CD44 in vivo requires both Ser 323 and ser 325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells

    EMBO J

    (1992)
  • C.M. Isacke

    The role of the cytoplasmatic domain in regulating CD44 function

    J Cell Sci

    (1994)
  • L.Y.W. Bourguignon et al.

    CD44 isoform–cytoskeleton interaction in oncogenic signaling and tumor progression

    Front Biosci

    (1998)
  • C. Tolg et al.

    Splicing choice from ten variant exons establishes CD44 variability

    Nucleic Acids Res

    (1993)
  • G.R. Screaton et al.

    Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons

    Proc Natl Acad Sci USA

    (1992)
  • K.K. Tanabe et al.

    Novel variants of CD44 arising from alternative splicing: changes in the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase

    Mol Carcinog

    (1993)
  • M.S. Sy et al.

    Inhibition of tumor growth in vivo with a soluble CD44–immunoglobulin fusion protein

    J Exp Med

    (1992)
  • S. Seiter et al.

    Prevention of tumor metastasis formation by anti-variant CD44

    J Exp Med

    (1993)
  • E. Galluzzo et al.

    Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T-cell

    Eur J Immunol

    (1995)
  • K. Yamamichi et al.

    Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer

    Int J Cancer

    (1998)
  • M. Hofmann et al.

    CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines

    Cancer Res

    (1991)
  • G. Koopman et al.

    Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44

    J Exp Med

    (1993)
  • M. Salmi et al.

    Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin

    J Cell Biol

    (1993)
  • Cited by (15)

    • Histone deacetylase SIRT1 controls proliferation, circadian rhythm, and lipid metabolism during liver regeneration in Mice

      2016, Journal of Biological Chemistry
      Citation Excerpt :

      Many factors, including hormones, cytokines, growth factors, and their coupled signal transduction pathways contribute to initiating and promoting progression of hepatocytes through the G1/S phase, and subsequent cell division (1). Several groups of genes are activated in a distinct temporal manner, thus maintaining the efficiency of the regenerative process (4–8). Moreover, specific metabolic changes are associated with the process of liver regeneration.

    • Enhanced expression of CD44 variants in human atheroma and abdominal aortic aneurysm: Possible role for a feedback loop in endothelial cells

      2004, American Journal of Pathology
      Citation Excerpt :

      Microvascular ECs express CD44H, CD44v3, CD44v6 (Figure 4), and CD44v7/8 (data not shown) in aneurysmal tissue containing very prominent neovascularization. Both CD44H and CD44v6 have been implicated in regulating cell proliferation.28–31 We therefore studied the protein levels of these isoforms in response to inflammatory mediators in more detail in cultured ECs.

    • Liver Regeneration and Immunity: A Tale to Tell

      2023, International Journal of Molecular Sciences
    View all citing articles on Scopus
    View full text